These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis. Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397 [TBL] [Abstract][Full Text] [Related]
4. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry]. Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641 [TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. Jo HE; Glaspole I; Grainge C; Goh N; Hopkins PM; Moodley Y; Reynolds PN; Chapman S; Walters EH; Zappala C; Allan H; Keir GJ; Hayen A; Cooper WA; Mahar AM; Ellis S; Macansh S; Corte TJ Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232409 [TBL] [Abstract][Full Text] [Related]
7. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Collard HR; Ryu JH; Douglas WW; Schwarz MI; Curran-Everett D; King TE; Brown KK Chest; 2004 Jun; 125(6):2169-74. PubMed ID: 15189938 [TBL] [Abstract][Full Text] [Related]
8. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis]. Li ZH; Peng SC; Kang J; Hou XM; Yu RJ Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406 [TBL] [Abstract][Full Text] [Related]
9. The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis. Tran T; Šterclová M; Mogulkoc N; Lewandowska K; Müller V; Hájková M; Kramer MR; Jovanović D; Tekavec-Trkanjec J; Studnicka M; Stoeva N; Hejduk K; Dušek L; Suissa S; Vašáková M; Respir Res; 2020 Jan; 21(1):11. PubMed ID: 31915023 [TBL] [Abstract][Full Text] [Related]
10. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786 [TBL] [Abstract][Full Text] [Related]
11. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Alakhras M; Decker PA; Nadrous HF; Collazo-Clavell M; Ryu JH Chest; 2007 May; 131(5):1448-53. PubMed ID: 17400656 [TBL] [Abstract][Full Text] [Related]
12. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis. Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978 [TBL] [Abstract][Full Text] [Related]
14. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Hubbard R; Johnston I; Britton J Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958 [TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients. Greater Manchester Lung Fibrosis Consortium. Lok SS J Heart Lung Transplant; 1999 Sep; 18(9):884-90. PubMed ID: 10528751 [TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy. Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y Respiration; 2016; 92(4):220-228. PubMed ID: 27576553 [TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis. Vainshelboim B; Oliveira J; Fox BD; Kramer MR Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419 [TBL] [Abstract][Full Text] [Related]
18. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738 [TBL] [Abstract][Full Text] [Related]
19. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684 [TBL] [Abstract][Full Text] [Related]
20. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage. Shioya M; Otsuka M; Yamada G; Umeda Y; Ikeda K; Nishikiori H; Kuronuma K; Chiba H; Takahashi H Can Respir J; 2018; 2018():6043053. PubMed ID: 30186537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]